FDA clears Avantis' Third Eye Retroscope for detection of colon polyps
This article was originally published in Clinica
Avantis Medical Systems' Third Eye Retroscope has received US FDA 510(k) clearance to detect cancerous and precancerous polyps in the colon. Third Eye is used with colonoscopy to give a backward view of the colon, as well as the standard forward view. This "rear view mirror" can detect polyps in blind spots in the colon that might otherwise be missed. Although colonoscopy is regarded as the gold standard, it can miss 12-24% of polyps and a significant number of cancers, studies have shown. Sunnyvale, California-based Avantis said that Third Eye detected 13% more polyps and 10.9% more adenomas than colonoscopy alone in one study.